Senti Biosciences Files Proxy Statement for July Meeting

TL;DR

Senti Bio proxy filed for July 10th meeting - vote your shares!

AI Summary

Senti Biosciences, Inc. filed a Definitive Proxy Statement (DEF 14A) on May 29, 2024, for its annual meeting on July 10, 2024. The filing concerns the election of directors and other corporate matters. The company, previously known as Dynamics Special Purpose Corp., is incorporated in Delaware and operates in the biological products sector.

Why It Matters

This filing provides shareholders with crucial information regarding the company's governance and upcoming decisions, including director elections, which can impact the company's strategic direction.

Risk Assessment

Risk Level: medium — Proxy statements are routine filings, but the specific proposals and director elections can carry inherent risks depending on the company's situation and shareholder sentiment.

Key Numbers

• 20240710 — Meeting Date (Annual meeting date for shareholders to vote on proposals.)
• 20240529 — Filing Date (Date the proxy statement was filed with the SEC.)

Key Players & Entities

• Senti Biosciences, Inc. (company) — Registrant
• Dynamics Special Purpose Corp. (company) — Former Company Name
• July 10, 2024 (date) — Meeting Date
• May 29, 2024 (date) — Filing Date

FAQ

Key Financial Figures

• $0.0001 — f the Company's common stock, par value $0.0001 per share, at a ratio ranging from any
• $1.235 billion — gross revenue is equal to or more than $1.235 billion (iii) the date on which we have issued
• $1 billion — date on which we have issued more than $1 billion in nonconvertible debt during the previ

Filing Documents

• a20240529def14adocsentibio.htm (DEF 14A) — 580KB
• image_1a.jpg (GRAPHIC) — 19KB
• proxycard_p1a.jpg (GRAPHIC) — 183KB
• proxycard_p2a.jpg (GRAPHIC) — 134KB
• 0001854270-24-000069.txt ( ) — 1044KB

From the Filing

DEF 14A 1 a20240529def14adocsentibio.htm DEFINITIVE PROXY Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.____) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement o Definitive Additional Materials o Soliciting Material under 240.14a-12 SENTI BIOSCIENCES, INC. (Name of registrant as specified in its charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply) x No fee required. o Fee paid previously with preliminary materials o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 SENTI BIOSCIENCES, INC. 2 Corporate Drive, First Floor South San Francisco, CA, 94080 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS To be held July 10, 2024 Notice is hereby given that the 2024 Annual Meeting of Stockholders, or the Annual Meeting, of Senti Biosciences, Inc., or the Company or our, will be held online on July 10, 2024 at 900 a.m. Pacific Time. This year's Annual Meeting will be held virtually. You may attend the meeting virtually via the Internet at www.virtualshareholdermeeting.comSNTI2024, where you will be able to vote electronically and submit questions. You will need the 16-digit control number included with the Notice of Internet Availability of Proxy Materials being mailed to you separately in order to attend the Annual Meeting. The purpose of the Annual Meeting is the following 1. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 2. To approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation to include an officer exculpation provision that limits the liability of certain of our officers as permitted under current Delaware law 3. To approve amendments to the Company's Second Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock, par value $0.0001 per share, at a ratio ranging from any whole number between 1-for-5 and 1-for-30, as determined by our board of directors in its discretion, subject to our board of directors' authority to abandon such amendments 4. To approve the adjournment of the Annual Meeting to solicit additional proxies to the extent there are insufficient votes at the Annual Meeting to approve Proposals No. 2 and 3 and 5. To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting. These items of business are more fully described in the Proxy Statement accompanying this Notice. The Board of Directors has fixed the close of business on May 13, 2024 as the record date for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting of Stockholders, or at any adjournments of the Annual Meeting of Stockholders. The Company is following the Securities and Exchange Commission's "Notice and Access" rule that allows companies to furnish their proxy materials by posting them on the Internet. As a result, we are mailing to our stockholders a Notice of Internet Availability of Proxy Materials, or the Notice, instead of a paper copy of the accompanying proxy statement and our Annual Report for the fiscal year ended December 31, 2023, or the 2023 Annual Report. We plan to mail the Notice on or about May 29, 2024 and it contains instructions on how to access both the 2023 Annual Report and accompanying proxy statement over the Internet. This method provides our stockholders with expedited access to proxy materials and not only lowers the cost of printing and distribution but also reduces the environmental impact of the Annual Meeting. If you would like to receive a print version of the proxy materials, free of charge, please follow the instructions on the Notice. In order to attend the Annual Meeting virtually, you will be required to enter the control number provided in the Notice or the proxy card at www.virtualshareholdermeeting.comSNTI2024. Beneficial owners of shares held in street name will need to follow the instructions provided in the voting instructions form by the broker, bank or other nominee that holds their shares. Please see the "General Information" section of the Proxy Statement that accompanies this notice for more details regarding the logistics of the virtual Annual Meeting, including the ability of stockholders to submit questions during the Annual Meeting, and technical details and support related to accessing the virtual platform. You will not be able to attend the Annual Meeting in person. Your vote is im

View Full Filing

View this DEF 14A filing on SEC EDGAR